The serious funding gap in innovative medicines requires more decisive solutions
Biopharmaceutical research is advancing at an impressive pace, offering cutting-edge therapies that are transforming healthcare, altering the natural course of many severe diseases, and significantly improving patients’ quality of life. This progress makes pharmaceutical policy a decisive factor for the efficiency and resilience of the healthcare system, necessitating a structural revision that ensures innovation is…